In T2D patients, naringin was found to improve glucose metabolism, increase residual insulin secretion, and stimulate glycogen synthesis; however, absolute insulin deficiency prevented it from regulating glucose levels in T1D patients, yet it could reverse T1D-induced DKA [206]. This evidence concerns the gene INS and type 2 diabetes mellitus.